LGP have complete supply chain control from cultivating, testing, processing, distribution and retail/patient, as well as R&D operations, clinical trials, genetic programs and the like.
To compare or call them just a 'cultivator' sort of undermines and undervalues the offering they have. They are already good to go with GMP certification which is going to kick in as mandatory later in the year while a lot of other companies will be chasing their tails trying to get certified or working a way around it.
The edge they have is that they don't have to rely on any external parties in order to bring their products to market, which might be an issue for some as the GMP cert hits, and suddenly "Australian" importers have to invest in making sure they comply which will probably see an increase in overheads in the 'frugal' companies.
- Forums
- ASX - By Stock
- Cannabis cultivators Comparisons
LGP have complete supply chain control from cultivating,...
-
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add LGP (ASX) to my watchlist
(20min delay)
|
|||||
Last
9.9¢ |
Change
-0.006(5.71%) |
Mkt cap ! $29.87M |
Open | High | Low | Value | Volume |
10.0¢ | 10.0¢ | 9.7¢ | $2.21K | 22.20K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 93495 | 9.7¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
9.9¢ | 2072 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 93495 | 0.097 |
2 | 125000 | 0.096 |
9 | 147581 | 0.095 |
1 | 150000 | 0.094 |
1 | 425000 | 0.093 |
Price($) | Vol. | No. |
---|---|---|
0.099 | 2072 | 1 |
0.100 | 184903 | 3 |
0.105 | 179243 | 5 |
0.110 | 189240 | 4 |
0.115 | 330400 | 4 |
Last trade - 16.10pm 26/07/2024 (20 minute delay) ? |
Featured News
LGP (ASX) Chart |